https://www.selleckchem.com/products/GDC-0449.html
Donor-derived, cell-free DNA (dd-cfDNA) level correlates with allograft injury with clinical validity and utility for quiescence and active acute rejection (AR) in kidney transplant recipients. We analyzed trends in dd-cfDNA level immediately preceding and during the coronavirus disease 2019 (COVID-19) pandemic with implemented "shelter in place" and a tele-health strategy with remote home phlebotomy to limit COVID-19 exposure. During COVID-19 in the United States (US), we surveyed weekly (January 6, 2020-May 25, 202 metrics for dd-c
Like
Comment
Share
